Shalby Ltd.
Snapshot View

124.55 +7.10 ▲6.1%

16 August 2022, 02:58:44 PM
Volume: 118,414

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.shalby.org
Market Cap 1,298.82 Cr.
Enterprise Value(EV) 1,317.35 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 5.00 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 24.04 Trailing Twelve Months Ending 2022-06
Industry PE 46.92 Trailing Twelve Months Ending 2022-06
Book Value / Share 84.13 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.43 Calculated using Price: 120.25
Dividend Yield 0.83 Period Ending 2021-03
No. of Shares Subscribed 10.80 Cr. 108,009,770 Shares
FaceValue 10
Company Profile
The company is one of the leading multi-specialty chains of hospitals in India. Its hospitals are tertiary care hospitals, few of which also offer quaternary healthcare services to patients in various areas of specialisation such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+6.05%
1 Week
+1.67%
1 Month
+13.23%
3 Month
+18.17%
6 Month
-8.92%
1 Year
-34.07%
2 Year
+44.74%
5 Year
10 Year
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 14.79 31.21 15.92 19.50 12.60 7.81 4.13 3.49 5.19
Return on Capital Employed (%) 17.84 38.23 21.84 13.34 12.21 9.15 6.94 7.49 6.85
Return on Assets (%) 9.88 20.47 8.64 8.49 4.61 4.42 3.12 2.72 4.05

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 102 141 168 205 251 751 780 799 835 876
Non Curr. Liab. 10 33 90 207 291 140 130 144 150 145
Curr. Liab. 36 40 90 92 199 138 88 83 82 172
Minority Int. 4 3 2 0 -1 0 0 0 0 0
Equity & Liab. 152 217 351 504 741 1,030 998 1,027 1,066 1,194
Non Curr. Assets 125 154 289 440 582 794 801 793 795 743
Curr. Assets 27 63 63 64 159 236 197 234 271 451
Misc. Exp. not W/O
Total Assets 152 217 351 504 741 1,030 998 1,027 1,066 1,194

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 225 259 275 290 324 378 462 487 431 708
Other Income 5 3 2 2 7 10 9 17 9 14
Total Income 230 262 278 293 331 388 472 504 440 722
Total Expenditure -184 -196 -208 -235 -252 -299 -379 -404 -344 -587
PBIDT 46 66 70 58 78 89 93 100 96 136
Interest 0 -2 -5 -10 -11 -12 -9 -7 -5 -7
Depreciation -27 -11 -21 -11 -17 -23 -33 -36 -37 -45
Taxation -4 -14 -18 0 -22 -15 -19 -29 -13 -25
Exceptional Items -4
PAT 15 38 25 36 29 39 32 28 42 54
Minority Interest 2 1 1 1 1 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 17 39 26 38 30 39 32 28 42 54
Adjusted EPS 5 11 7 4 3 4 3 3 4 5

Cash Flow View Details >>

Particulars 9 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 95 5 123 5 60 14 43 55 84
Cash Fr. Inv. -9 -26 -62 -98 -153 -237 1 -31 -57
Cash Fr. Finan. -86 24 -39 75 96 222 -51 -22 -29
Net Change 0 3 22 -19 3 0 -6 3 -2
Cash & Cash Eqvt 2 6 27 9 12 12 5 8 6

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 79.44 79.45 79.45 79.45 74.07 74.02 74.02 74.02 74.04
Public 20.56 20.55 20.55 20.55 25.93 25.98 25.98 25.98 25.97
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 04 Aug 2022
General updates
Shalby Limited has informed the Exchange about Terms of grant of options.
Wed, 03 Aug 2022
General updates
Shalby Limited has informed the Exchange about Terms of grant of options.
Tue, 02 Aug 2022
Transcript of Analysts/Institutional Investor Meet/Con. Call
Shalby Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call held on July 28, 2022 for discussion on Unaudited financial results for quarter ended June 30, 2022.

Technical Scans View Details >>

Fri, 12 Aug 2022
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months
High Decrease 1 Year High Decrease 1 Year
20 SMA Crossing  100 SMA From Below 20 SMA Crossing 100 SMA From Below
Thu, 11 Aug 2022
High Increase 1 Month High Increase 1 Month

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 912.95 0.0%
Divi's Laboratories Ltd. 98,918.90 3,714.95 -0.3%
Cipla Ltd. 82,906.37 1,030.10 +0.3%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,294.00 +0.8%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,333.00 +0.5%
Torrent Pharmaceuticals Ltd. 51,917.53 1,563.05 +1.5%
Piramal Enterprises Ltd. 45,855.65 1,924.95 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 912.95 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,714.95 -0.3%
Cipla Ltd. Consolidated 2022-06 33.32 1,030.10 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,294.00 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,333.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,563.05 +1.5%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,924.95 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 912.95 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,714.95 -0.3%
Cipla Ltd. Consolidated 2022-06 3.86 1,030.10 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,294.00 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,333.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,563.05 +1.5%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,924.95 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 912.95 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,714.95 -0.3%
Cipla Ltd. Consolidated 2022-03 0.04 1,030.10 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,294.00 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,333.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,563.05 +1.5%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,924.95 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 912.95 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,714.95 -0.3%
Cipla Ltd. Consolidated 2022-03 13.10 1,030.10 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,294.00 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,333.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,563.05 +1.5%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,924.95 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 912.95 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,714.95 -0.3%
Cipla Ltd. Consolidated 2022-03 13.10 1,030.10 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,294.00 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,333.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,563.05 +1.5%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,924.95 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 912.95 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,714.95 -0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,030.10 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,294.00 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,333.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,563.05 +1.5%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,924.95 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 912.95 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,714.95 -0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,030.10 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,294.00 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,333.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,563.05 +1.5%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,924.95 +0.2%

FAQ's On Shalby Ltd.

Can I Buy Shalby Shares now?

What is the Share Price of Shalby?

What is the Relative Strength Index (RSI) Value of Shalby?

What is the Market Capital (MCAP) of Shalby?

What are the key metrics to analyse Shalby?

What is the Price Performance of Shalby?